Protection against hepatitis B was detected in 64% of patients, with 22% (15/69) being anti-HBs positive after hepatitis B vaccination and 42% (29/69) showing anti-HBs and anti-HBc antibodies after past HBV infection. The gene discussed is KRT88P; the disease is hepatitis B virus infection.